etodolac has been researched along with Osteoarthritis, Hip in 4 studies
Etodolac: A non-steroidal anti-inflammatory agent and cyclooxygenase-2 (COX-2) inhibitor with potent analgesic and anti-arthritic properties. It has been shown to be effective in the treatment of OSTEOARTHRITIS; RHEUMATOID ARTHRITIS; ANKYLOSING SPONDYLITIS; and in the alleviation of postoperative pain (PAIN, POSTOPERATIVE).
etodolac : A monocarboxylic acid that is acetic acid in which one of the methyl hydrogens is substituted by a 1,8-diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indol-1-yl moiety. A preferential inhibitor of cyclo-oxygenase 2 and non-steroidal anti-inflammatory, it is used for the treatment of rheumatoid arthritis and osteoarthritis, and for the alleviation of postoperative pain. Administered as the racemate, only the (S)-enantiomer is active.
Osteoarthritis, Hip: Noninflammatory degenerative disease of the hip joint which usually appears in late middle or old age. It is characterized by growth or maturational disturbances in the femoral neck and head, as well as acetabular dysplasia. A dominant symptom is pain on weight-bearing or motion.
Excerpt | Relevance | Reference |
---|---|---|
"The efficacy of etodolac (600 mg/day) and placebo were compared in a 4-week double-blind, parallel-group study involving 104 patients with osteoarthritis of the knee and 106 with osteoarthritis of the hip." | 9.06 | Etodolac therapy for osteoarthritis: a double-blind, placebo-controlled trial. ( Hosie, J; Scott, DL; Williams, PI, 1989) |
"An open clinical trial was carried out in 57 patients with osteoarthritis of the knee, hip or spine to assess the effectiveness and tolerability of etodolac." | 7.67 | Efficacy and tolerability of etodolac in the treatment of osteoarthritis. ( Ciocci, A, 1989) |
"The efficacy of etodolac (600 mg/day) and placebo were compared in a 4-week double-blind, parallel-group study involving 104 patients with osteoarthritis of the knee and 106 with osteoarthritis of the hip." | 5.06 | Etodolac therapy for osteoarthritis: a double-blind, placebo-controlled trial. ( Hosie, J; Scott, DL; Williams, PI, 1989) |
"An open clinical trial was carried out in 57 patients with osteoarthritis of the knee, hip or spine to assess the effectiveness and tolerability of etodolac." | 3.67 | Efficacy and tolerability of etodolac in the treatment of osteoarthritis. ( Ciocci, A, 1989) |
" Improvement in force transmission was dosage dependent for the primary outcome measurement (vertical impulse)." | 2.69 | Efficacy of etodolac for the treatment of osteoarthritis of the hip joints in dogs. ( Budsberg, SC; Claxton, R; DeCamp, CE; Johnston, SA; Schwarz, PD, 1999) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (50.00) | 18.7374 |
1990's | 1 (25.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Budsberg, SC | 1 |
Johnston, SA | 1 |
Schwarz, PD | 1 |
DeCamp, CE | 1 |
Claxton, R | 1 |
Mejjad, O | 1 |
Favre, S | 1 |
Dujardin, F | 1 |
Thomine, J | 1 |
Le Loët, X | 1 |
Weber, J | 1 |
Williams, PI | 1 |
Hosie, J | 1 |
Scott, DL | 1 |
Ciocci, A | 1 |
3 trials available for etodolac and Osteoarthritis, Hip
Article | Year |
---|---|
Efficacy of etodolac for the treatment of osteoarthritis of the hip joints in dogs.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cyclooxygenase Inhibitors; Dog Diseases; Dogs; Dos | 1999 |
Efficacy of etodolac on gait in hip osteoarthritis as assessed by Bessou's locometer: a randomized, crossover, double-blind study versus placebo. Groupe de Recherche sur le Handicap de L'appareil Locomoteur.
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Cross-Over Studies; Double-Blind Method; Etodo | 2000 |
Etodolac therapy for osteoarthritis: a double-blind, placebo-controlled trial.
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Clinical Trials as Topic; Double-Blind Method; | 1989 |
1 other study available for etodolac and Osteoarthritis, Hip
Article | Year |
---|---|
Efficacy and tolerability of etodolac in the treatment of osteoarthritis.
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Etodolac; Female; Humans; Indoleacetic Acids; | 1989 |